Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 25 of 10509 for:    strength

Changes in Grip Strength by Using Bandage Kinesio Taping

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02585037
Recruitment Status : Completed
First Posted : October 23, 2015
Last Update Posted : October 27, 2015
Sponsor:
Information provided by (Responsible Party):
Silvia Regina M. S. Boschi, University of Mogi das Cruzes

Brief Summary:
The Kinesio Taping® method, therapeutic bandage, is another feature can be used in physical therapy, aiming to muscle enhancement, weakened muscles correction, analgesia, among others, by cutaneous stimulation of mechanoreceptors. This study aims to evaluate the efficiency of the use and effects offered by Kinesio Taping® method, changes in muscle strength of grip in normal subjects for clinical application.

Condition or disease Intervention/treatment Phase
Hand Strength Other: Kinesio Taping® bandage Other: Dynamometer Jamar® pressure Other: Placebo Not Applicable

Detailed Description:
A sample of 45 subjects will be divided randomly into three groups (G1: muscle activation technique; G2: muscle inhibition technique; G3: Placebo Effect) aged over 18 years male or female, where it will be initially measured the strength of grip with a dynamometer Jamar® pressure. Then the Kinesio Taping® bandage will be applied in an "I" format in the wrist flexor muscles of a dominant and non-dominant limb in G1, G2, and G3 groups. Investigators will follow the application protocol suggested by method of technical. To provide the facilitation of muscle activity (G1 group) a Kinesio Taping® bandage will be applied to the muscle starting at its origin up to the location of muscle insertion. For inhibition of muscle activity (G2 group), the bandage will be placed over the muscle starting at the insertion location and ending at the muscle origin. For the control group (G3 group) the bandage will be placed from the lateral extremity to the medial axis. The measurement of grip strength was carried out in four stages: immediately before placing the Kinesio Taping®, 24 h, 48 h, and 72 h after its application. After collecting the data statistical Investigators will held the analysis of the data.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 45 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Investigator)
Official Title: Changes in Grip Strength by Using Bandage Kinesio Taping
Study Start Date : August 2015
Actual Primary Completion Date : August 2015
Actual Study Completion Date : August 2015

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Flu

Arm Intervention/treatment
Experimental: Kinesio Taping for facilitation
To provide the facilitation of muscle activity (G1 group) a Kinesio Taping® bandage will be applied to the muscle starting at its origin up to the location of muscle insertion. Bandage in group G1 will be applied following the protocol proposed by method of technical, which defined the direction of the bandage and an applied tension of 10% to 15% (paper off). With a dynamometer Jamar® pressure the grip strength will be messure in four stages: immediately before placing the Kinesio Taping®, 24 h, 48 h, and 72 h after its application.
Other: Kinesio Taping® bandage
The Kinesio Taping® bandage will be applied in an "I" format in the wrist flexor muscles of a dominant and non-dominant limb in G1 and G2 groups.

Other: Dynamometer Jamar® pressure
The Jamar® dynamometer will be adjusted to the second position for measurement of maximal voluntary strength of handgrip. A muscle contraction period of three seconds will be performed in order to record handgrip strength.

Experimental: Kinesio Taping for inhibition
For inhibition of muscle activity (G2 group), the Kinesio Taping® bandage will be placed over the muscle starting at the insertion location and ending at the muscle origin. Bandage in group G2 will be applied following the protocol proposed by method of technical, which defined the direction of the bandage and an applied tension of 10% to 15% (paper off). With a dynamometer Jamar® pressure the grip strength will be messure in four stages: immediately before placing the Kinesio Taping®, 24 h, 48 h, and 72 h after its application.
Other: Kinesio Taping® bandage
The Kinesio Taping® bandage will be applied in an "I" format in the wrist flexor muscles of a dominant and non-dominant limb in G1 and G2 groups.

Other: Dynamometer Jamar® pressure
The Jamar® dynamometer will be adjusted to the second position for measurement of maximal voluntary strength of handgrip. A muscle contraction period of three seconds will be performed in order to record handgrip strength.

Placebo Comparator: Kinesio Taping and Placebo
For the control group (G3 group) the Kinesio Taping® bandage will be placed from the lateral extremity to the medial axis. Bandages in the G3 group will be applied laterally to produce a similar visual effect, which control for the placebo effect, but without tension so that a muscle stimulus will be not generated. With a dynamometer Jamar® pressure the grip strength will be messure in four stages: immediately before placing the Kinesio Taping®, 24 h, 48 h, and 72 h after its application.
Other: Dynamometer Jamar® pressure
The Jamar® dynamometer will be adjusted to the second position for measurement of maximal voluntary strength of handgrip. A muscle contraction period of three seconds will be performed in order to record handgrip strength.

Other: Placebo
For the control group (G3) the Kinesio Taping® bandage will be placed from the lateral extremity to the medial axis.




Primary Outcome Measures :
  1. Change handgrip strength at 72 hours [ Time Frame: 24, 48 and 72 hours ]
    At each stage (24, 48 and 72 hours) the volunteer must perform the measurement of strength three times respecting a period of rest between measurements than a minute.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Men or women aged greater than 18 years and with muscle / nerve integrity of upper limbs, hearing and responsive to verbal commands with understanding the information that aware and according to the study.

Exclusion Criteria:

  • Individuals who refused to participate in this research and / or do not meet the inclusion criteria.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02585037


Sponsors and Collaborators
University of Mogi das Cruzes
Investigators
Layout table for investigator information
Principal Investigator: Silvia R. Boschi, PhD University of Mogi das Cruzes

Layout table for additonal information
Responsible Party: Silvia Regina M. S. Boschi, PhD, University of Mogi das Cruzes
ClinicalTrials.gov Identifier: NCT02585037     History of Changes
Other Study ID Numbers: 17119213.0.0000.5497
First Posted: October 23, 2015    Key Record Dates
Last Update Posted: October 27, 2015
Last Verified: October 2015